Amino Drive Strawberry Kiwi
Nutrex Research Black Series Amino Drive Strawberry Kiwi is an amino acid supplement formulated to support muscle recovery and growth. Each 8.7 gram serving delivers a blend of branched-chain amino acids (BCAAs), with L-Leucine provided at a clinically studied dose of 2.5 grams. The product also contains L-Isoleucine (1.25 grams) and L-Valine (1.25 grams), maintaining a typical 2:1:1 BCAA ratio. This product achieves an N+ Score of 72 and a 'C' grade, indicating good quality. With a concise list of 4 ingredients and transparent labeling, it is a suitable option for individuals seeking targeted BCAA supplementation, particularly around workouts.
About This Product
Amino Drive Strawberry Kiwi by Nutrex Research Black Series is a protein supplement containing 4 active ingredients. It has earned an N+ Score of 72/100 (Grade C).
This product features a fully transparent label with individual ingredient amounts disclosed, and key ingredients are present at clinically effective doses based on peer-reviewed research.
Notable clinical-dose ingredients include L-Leucine.
N+ Score Breakdown
Are key ingredients present at clinically effective doses based on research?
Does the product include all expected ingredients for its supplement category?
Are individual ingredient amounts clearly disclosed without proprietary blends?
Does the formula include a breadth of beneficial compounds from multiple pathways?
Strengths
- +Key ingredients at clinically effective doses
- +Fully transparent label with individual ingredient amounts disclosed
- +Broad ingredient diversity exceeding category norms
- +1 ingredient(s) at clinical dose levels
Weaknesses
- −Missing several expected ingredients for its category
Ingredient Analysis (4 ingredients)
| Ingredient | Amount | Dose Adequacy |
|---|---|---|
| Sodium | 80.000 mg | N/A |
| L-Leucine | 2.500 Gram(s) | Optimal |
| L-Isoleucine | 1.250 Gram(s) | N/A |
| L-Valine | 1.250 Gram(s) | N/A |
Clinical ranges based on NIH ODS Fact Sheets and peer-reviewed research. Status indicates whether the amount meets evidence-based thresholds.
